dc.contributor.author | Walsh, Garry Michael | |
dc.date.accessioned | 2013-03-15T10:29:01Z | |
dc.date.available | 2013-03-15T10:29:01Z | |
dc.date.issued | 2013-01-09 | |
dc.identifier.citation | Walsh , G M 2013 , ' Profile of reslizumab in eosinophilic disease and its potential in the treatment of poorly controlled eosinophilic asthma ' , Biologics: Targets & Therapy , vol. 7 , pp. 7-11 . https://doi.org/10.2147/BTT.S30133 | en |
dc.identifier.issn | 1177-5475 | |
dc.identifier.other | PURE: 20890796 | |
dc.identifier.other | PURE UUID: 12123d6c-27d1-46f5-b329-ae02a2066ff2 | |
dc.identifier.uri | http://hdl.handle.net/2164/2709 | |
dc.format.extent | 5 | |
dc.language.iso | eng | |
dc.relation.ispartof | Biologics: Targets & Therapy | en |
dc.rights | Biologics: Targets & Therapy, Dove Medical Press DOI: 10.2147/BTT.S30133 | en |
dc.subject | IL-5 | en |
dc.subject | asthma | en |
dc.subject | eosinophil | en |
dc.subject | R Medicine | en |
dc.subject.lcc | R | en |
dc.title | Profile of reslizumab in eosinophilic disease and its potential in the treatment of poorly controlled eosinophilic asthma | en |
dc.type | Journal article | en |
dc.contributor.institution | University of Aberdeen.Applied Medicine | en |
dc.description.status | Peer reviewed | en |
dc.description.version | Publisher PDF | en |
dc.identifier.doi | https://doi.org/10.2147/BTT.S30133 | |